KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
DMA 100DMA 200DMA 50Dividend YieldEV to CFOEV to EBITEV to EBITDAEV to FCFEV to RevenueEnterprise ValueMarket Cap to FCFMarket CapitalizationPricePrice to EarningsPrice to Sales
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Merck (MRK) Enterprise Value (2016 - 2026)

Merck has reported Enterprise Value over the past 18 years, most recently at -$5.6 billion for Q1 2026.

  • Quarterly Enterprise Value rose 38.35% to -$5.6 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$5.6 billion through Mar 2026, up 38.35% year-over-year, with the annual reading at -$14.5 billion for FY2025, 6.45% down from the prior year.
  • Enterprise Value was -$5.6 billion for Q1 2026 at Merck, up from -$14.5 billion in the prior quarter.
  • Over five years, Enterprise Value peaked at -$5.6 billion in Q1 2024 and troughed at -$18.2 billion in Q3 2025.
  • The 5-year median for Enterprise Value is -$10.1 billion (2022), against an average of -$10.4 billion.
  • Year-over-year, Enterprise Value skyrocketed 46.37% in 2023 and then crashed 93.64% in 2024.
  • A 5-year view of Enterprise Value shows it stood at -$13.1 billion in 2022, then soared by 46.37% to -$7.0 billion in 2023, then tumbled by 93.64% to -$13.6 billion in 2024, then fell by 6.45% to -$14.5 billion in 2025, then soared by 61.07% to -$5.6 billion in 2026.
  • Per Business Quant, the three most recent readings for MRK's Enterprise Value are -$5.6 billion (Q1 2026), -$14.5 billion (Q4 2025), and -$18.2 billion (Q3 2025).